STEPHANIE SANTOS: Open Payments
NPI 1942843719 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 78 payments from 18 companies in 2025. Trend: 2023 $2,738 · 2024 $1,976 · 2025 $1,556
Food & beverage: $1,513Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $235 |
| GENZYME CORPORATION | 5 | $192 |
| E.R. Squibb & Sons, L.L.C. | 17 | $174 |
| UCB, Inc. | 5 | $137 |
| Incyte Corporation | 5 | $117 |
| Organon LLC | 5 | $97 |
| Amgen Inc. | 6 | $93 |
| PFIZER INC. | 4 | $73 |
| LEO Pharma Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
Products named: DUPIXENT, SKYRIZI, Sotyktu, Bimzelx, OPZELURA, OTEZLA, CIBINQO, TREMFYA.
Industry payments across CA — which companies pay providers there.
